Education
About Us
Working with TipRanks
Follow Us
Csl Ltd (CSLLY)
:CSLLY
CSLLY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$65.44 - $101.18
Previous CloseN/A
Volume10.38K
Average Volume (3M)99.70K
Market Cap
$63.74B
Enterprise Value$87.76B
Total Cash (Recent Filing)$2.16B
Total Debt (Recent Filing)$11.54B
Price to Earnings (P/E)21.1
Beta0.47
Next Earnings
Feb 10, 2026EPS EstimateN/A
Last Dividend Ex-Date
Sep 10, 2025Dividend Yield2.17%
Share Statistics
EPS (TTM)1.03
Shares Outstanding970,302,800
10 Day Avg. Volume44,397
30 Day Avg. Volume99,703
Financial Highlights & Ratios
PEG Ratio1.91
Price to Book (P/B)3.97
Price to Sales (P/S)4.97
P/FCF Ratio30.14
Enterprise Value/Market Cap1.38
Enterprise Value/Revenue5.67
Enterprise Value/Gross Profit11.49
Enterprise Value/Ebitda16.77
Forecast
1Y Price Target
$99.00Price Target Upside50.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
CSL News
CSLLY FAQ
What was Csl Ltd’s price range in the past 12 months?
Csl Ltd lowest stock price was $65.44 and its highest was $101.18 in the past 12 months.
What is Csl Ltd’s market cap?
Csl Ltd’s market cap is $63.74B.
When is Csl Ltd’s upcoming earnings report date?
Csl Ltd’s upcoming earnings report date is Feb 10, 2026 which is in 140 days.
How were Csl Ltd’s earnings last quarter?
Csl Ltd released its earnings results on Aug 18, 2025. The company reported $1.028 earnings per share for the quarter, beating the consensus estimate of N/A by $1.028.
Is Csl Ltd overvalued?
According to Wall Street analysts Csl Ltd’s price is currently Undervalued.
Does Csl Ltd pay dividends?
Csl Ltd pays a Semiannually dividend of $0.81 which represents an annual dividend yield of 2.17%. See more information on Csl Ltd dividends here
What is Csl Ltd’s EPS estimate?
Csl Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Csl Ltd have?
Csl Ltd has 970,302,800 shares outstanding.
What happened to Csl Ltd’s price movement after its last earnings report?
Csl Ltd reported an EPS of $1.028 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -17.176%.
Which hedge fund is a major shareholder of Csl Ltd?
Currently, no hedge funds are holding shares in CSLLY
CSL Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$99.00 (50.80% Upside)
$99.00 (50.80% Upside)
Hedge Fund Trend
Decreased
By 33.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-32.94%
12-Months-Change
Fundamentals
Return on Equity
16.36%
Trailing 12-Months
Asset Growth
3.63%
Trailing 12-Months
Company Description
Csl Ltd
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioedema, Alpha-1 antitrypsin deficiency, and neurological disorders. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
CSLLY Company Deck
CSLLY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
CSL demonstrated solid revenue and profit growth, introduced transformative corporate strategies including a demerger and share buyback, and achieved operational efficiencies. However, challenges in Seqirus revenue growth, impacts from U.S. healthcare reforms, and the need for significant cost reductions in R&D and plasma centers indicate some operational pressures.View all CSLLY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---